TIRZ (30MG)
This product is prepared for LABORATORY RESEARCH USE ONLY and may not be used for other purposes.
$329.99
Out of stock
This product is currently sold out.
Don't worry! Enter your email and we'll notify you when it's available again.
Tirzepatide is a peptide designed to mimic the action of incretin hormones, such as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). As an agonist of both GIP and GLP-1 receptors, it is investigated in preclinical research on incretin receptor signaling, including glucose-dependent insulin secretion, glucagon secretion, hepatic glucose production and gastric emptying.
The 30mg tirzepatide vial is one of our larger single-vial presentations, suited to laboratories with an ongoing program that would otherwise consume several smaller lots. Tirzepatide is a dual GIP and GLP-1 receptor agonist, supplied strictly as a reference material for research and analytical use. Each vial is sealed, batch labeled, and independently tested for identity, purity and mass, and the matching certificate of analysis is published on our lab results page so the report can be reconciled with the physical material before work begins. Orders ship from the United States with tracking. This listing is for research use only. It is not a supplement, not a consumer product, and not for human or veterinary use. No dosing, administration or clinical guidance is provided, and buyers are responsible for confirming lawful possession and laboratory use in their jurisdiction.
| CAS Number | 2023788-19-2 |
|---|---|
| PubChem CID | 156588324 |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | 4813.93 g/mol |
| Storage | Refrigeration is necessary after reconstituting. Keep in a sealed and dark container. |












